Sign up
Quantellect · Congress · Trade Detail
LJPCLA JOLLA PHARMACEUTICAL COMPANY COM PAR S.0001 2 (LJPC)
RepublicanHouse

James B. Renacci sold LA JOLLA PHARMACEUTICAL COMPANY COM PAR S.0001 2 (LJPC) (LJPC)

James B. Renacci (R-OH), a U.S. Representative, has disclosed 2 trades in LA JOLLA PHARMACEUTICAL COMPANY COM PAR S.0001 2 (LJPC) (LJPC) since 2017, all sales, worth an estimated $16K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a sale: James B. Renacci sold $1,000 - $15,000 of LA JOLLA PHARMACEUTICAL COMPANY COM PAR S.0001 2 (LJPC) (LJPC) on September 7, 2017. Since that trade, LJPC is up +0.00% against the S&P 500 up +239.11%, an outperformance of -239.11%.

Across these filings, James B. Renacci has been a net seller of LJPC. The most recent disclosed LJPC transaction shown was dated December 15, 2017. Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

LJPC trades
2
Disclosed Vol
$16K
Buys
0
0%
Sells
2
100%
Buy / Sell
0.00
ratio
First → Last
2017

James B. Renacci's LJPC trades vs the price

LJPC is up +0.00% since James B. Renacci sold on September 7, 2017, versus +239.11% for the S&P 500.

Performance since this trade

Price change since trade
+0.00%
S&P 500 change since trade
+239.11%
Outperformance vs S&P 500
-239.11%

All James B. Renacci LJPC trades

TradedTypeSizeReturnEst. profit
December 15, 2017SELL$1,000 - $15,000N/A
September 7, 2017SELL$1,000 - $15,000N/A

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

James B. Renacci & LJPC trading FAQ

Is it legal for James B. Renacci to trade LA JOLLA PHARMACEUTICAL COMPANY COM PAR S.0001 2 (LJPC) (LJPC) stock?

Yes. Members of Congress are allowed to trade individual stocks, including LA JOLLA PHARMACEUTICAL COMPANY COM PAR S.0001 2 (LJPC) (LJPC), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did James B. Renacci sell LJPC?

James B. Renacci disclosed a sale of $1,000 - $15,000 of LA JOLLA PHARMACEUTICAL COMPANY COM PAR S.0001 2 (LJPC) (LJPC) on September 7, 2017, according to public STOCK Act filings.

How has LJPC performed since James B. Renacci's trade?

Since James B. Renacci sold LJPC on September 7, 2017, the stock is up +0.00%, versus +239.11% for the S&P 500 over the same period, an outperformance of -239.11%.

How many times has James B. Renacci traded LJPC?

James B. Renacci has disclosed 2 LJPC trades since 2017. Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional LJPC trades?

Quantellect tracks every disclosed congressional trade in LA JOLLA PHARMACEUTICAL COMPANY COM PAR S.0001 2 (LJPC) (LJPC) on the LA JOLLA PHARMACEUTICAL COMPANY COM PAR S.0001 2 (LJPC) congressional trading page, which aggregates filings across all members of Congress.

James B. Renacci's LJPC tradesAll congressional filings for LA JOLLA PHARMACEUTICAL COMPANY COM PAR S.0001 2 (LJPC)James B. Renacci's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.